CEACAM5 and neoplasm: However, such precision in clinical decision making is hindered by the limited reliability of current clinical, pathological, and molecular predictors of chemoradioresistance in rectal carcinoma, such as tumor stage, tumor regression grade, tumor markers (carcinoembryonic antigen), circulating tumor DNA, DNA methylation level, and cancer-related inflammatory markers [10,11].